| Original language | English |
|---|---|
| Pages (from-to) | v627 |
| Journal | Lancet Oncology |
| Volume | 28 |
| Issue number | 5 |
| Publication status | Published - Sept 2017 |
ICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis
Research output: Contribution to journal › Article › peer-review